IL166194A0 - Plasma urotensin in human heart failure - Google Patents

Plasma urotensin in human heart failure

Info

Publication number
IL166194A0
IL166194A0 IL16619403A IL16619403A IL166194A0 IL 166194 A0 IL166194 A0 IL 166194A0 IL 16619403 A IL16619403 A IL 16619403A IL 16619403 A IL16619403 A IL 16619403A IL 166194 A0 IL166194 A0 IL 166194A0
Authority
IL
Israel
Prior art keywords
heart failure
human heart
urotensin
plasma
plasma urotensin
Prior art date
Application number
IL16619403A
Other languages
English (en)
Original Assignee
Inverness Medical Switzerland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0216505A external-priority patent/GB0216505D0/en
Application filed by Inverness Medical Switzerland filed Critical Inverness Medical Switzerland
Publication of IL166194A0 publication Critical patent/IL166194A0/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/5751—Corticotropin releasing factor [CRF] (Urotensin)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL16619403A 2002-07-11 2003-07-11 Plasma urotensin in human heart failure IL166194A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB0216191.7A GB0216191D0 (en) 2002-07-11 2002-07-11 Plasma urotensin in human heart failure
GBGB0216500.9A GB0216500D0 (en) 2002-07-11 2002-07-16 Plasma urotensin in human heart failure
GB0216505A GB0216505D0 (en) 2002-07-11 2002-07-17 Plasma urotensin in human heart failure
PCT/GB2003/003011 WO2004008140A2 (en) 2002-07-11 2003-07-11 Plasma urotensin in human heart failure

Publications (1)

Publication Number Publication Date
IL166194A0 true IL166194A0 (en) 2006-01-15

Family

ID=9940317

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16619403A IL166194A0 (en) 2002-07-11 2003-07-11 Plasma urotensin in human heart failure
IL166194A IL166194A (en) 2002-07-11 2005-01-09 Plasma urotensin in human heart failure

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL166194A IL166194A (en) 2002-07-11 2005-01-09 Plasma urotensin in human heart failure

Country Status (11)

Country Link
US (1) US20040077027A1 (de)
EP (1) EP1521967B1 (de)
JP (1) JP4602078B2 (de)
CN (1) CN100582782C (de)
AT (1) ATE430937T1 (de)
AU (1) AU2003281071B2 (de)
CA (1) CA2492787A1 (de)
DE (1) DE60327530D1 (de)
GB (2) GB0216191D0 (de)
IL (2) IL166194A0 (de)
WO (1) WO2004008140A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074194B2 (en) * 2003-05-19 2006-07-11 Ischemia Technologies, Inc. Apparatus and method for risk stratification of patients with chest pain of suspected cardiac origin
CN101185000A (zh) * 2005-03-29 2008-05-21 因弗因斯医药瑞士股份有限公司 监测患者的方法和装置
EP1722232A1 (de) * 2005-05-09 2006-11-15 F.Hoffmann-La Roche Ag Vorrichtungen und Verfahren zur Diagnose oder zur Früherkennung der kardialen Dysfunktion
EP1910843A2 (de) * 2005-07-11 2008-04-16 Inverness Medical Switzerland GmbH Assay
CN106908603B (zh) * 2007-01-25 2019-04-02 霍夫曼-拉罗奇有限公司 Igfbp-7在心力衰竭评估中的用途
JP5081930B2 (ja) * 2007-03-08 2012-11-28 エフ．ホフマン−ラ ロシュ アーゲー 心不全の評価におけるｓｌｉｍ−１の使用
WO2010043393A1 (en) * 2008-10-17 2010-04-22 Roche Diagnostics Gmbh Use of biglycan in the assessment of heart failure
WO2015175502A2 (en) * 2014-05-12 2015-11-19 Palatin Technologies, Inc. Replacement therapy for natriuretic peptide deficiencies
US11931207B2 (en) 2018-12-11 2024-03-19 Eko.Ai Pte. Ltd. Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device
US11446009B2 (en) 2018-12-11 2022-09-20 Eko.Ai Pte. Ltd. Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images
US12400762B2 (en) 2018-12-11 2025-08-26 Eko.Ai Pte. Ltd. Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and diagnosis of cardiac amyloidosis and hypertrophic cardiomyopathy
US12001939B2 (en) 2018-12-11 2024-06-04 Eko.Ai Pte. Ltd. Artificial intelligence (AI)-based guidance for an ultrasound device to improve capture of echo image views
US12322100B2 (en) 2018-12-11 2025-06-03 Eko.Ai Pte. Ltd. Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and grading of aortic stenosis severity
WO2025040754A1 (en) * 2023-08-22 2025-02-27 Roche Diagnostics Gmbh Monitoring of cardiovascular markers in interstitial fluid and its application in assessment of heart failure

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5710008B1 (en) * 1990-10-12 1999-09-07 Spectral Diagnostics Inc Method and device for diagnosing and distinguishing chest pain in early onset thereof
US5604105B1 (en) * 1990-10-12 1999-08-24 Spectral Diagnostics Inc Method and device for diagnosingand distinguishing chest pain in early onset thereof
CA2027434C (en) * 1990-10-12 1999-01-05 George Jackowski Diagnostic kit for diagnosing and distinguishing chest pain in early onset thereof
US6593456B1 (en) * 1996-11-06 2003-07-15 The Regents Of The University Of California Tumor necrosis factor receptor releasing enzyme
JP5264026B2 (ja) * 1997-06-10 2013-08-14 エルパス・インコーポレイテッド 心疾患の早期発見のための方法
WO1999035266A2 (en) * 1998-01-09 1999-07-15 Smithkline Beecham Corporation Human urotensin ii
US6075137A (en) * 1998-01-09 2000-06-13 Smithkline Beecham Corporation Human urotensin II
PL204235B1 (pl) * 1999-01-29 2009-12-31 Roche Diagnostics Gmbh Sposób wykrywania natywnego N-końcowego proBNP, zastosowanie tego sposobu, zastosowanie zrekombinowanego N-końcowego proBNP, przeciwciała przeciw zrekombinowanemu N-końcowemu proBNP, linie komórkowe i sposoby wytwarzania przeciwciał poliklonalnych i monoklonalnych
EP1241479B1 (de) * 2001-03-12 2007-08-01 Immundiagnostik AG Verfahren zur Bestimmung von Urotensin II in Körperflüssigkeiten und Diagnose von kardiovaskulären Krankheiten

Also Published As

Publication number Publication date
JP2005532564A (ja) 2005-10-27
EP1521967B1 (de) 2009-05-06
US20040077027A1 (en) 2004-04-22
JP4602078B2 (ja) 2010-12-22
ATE430937T1 (de) 2009-05-15
AU2003281071A1 (en) 2004-02-02
CA2492787A1 (en) 2004-01-22
GB0216500D0 (en) 2002-08-28
GB0216191D0 (en) 2002-08-21
WO2004008140A3 (en) 2004-05-06
CN1678912A (zh) 2005-10-05
AU2003281071B2 (en) 2007-12-13
WO2004008140A2 (en) 2004-01-22
IL166194A (en) 2010-11-30
CN100582782C (zh) 2010-01-20
DE60327530D1 (de) 2009-06-18
EP1521967A2 (de) 2005-04-13

Similar Documents

Publication Publication Date Title
GB0216500D0 (en) Plasma urotensin in human heart failure
AU2003240833A8 (en) Low profile inlet for an implantable blood pump
GB0329288D0 (en) Monitoring method and apparatus
WO2003069332A3 (en) Detection and/or monitoring of synuclein-related diseases
AU2003220377A1 (en) Sensor for transcutaneous measurement of vascular access blood flow
AU2003212608A8 (en) System and method for assessing and indicating the health of components
AU2003256132A8 (en) Automatic blood pressure measuring instrument and method thereof
AU2003274869A1 (en) A method and an apparatus for determining the efficiency of dialysis
EP2260942A3 (de) Probenahmesystem mit proteasehemmer
AU2003214214A8 (en) Method for treating congestive heart failure
AU2003303287A8 (en) Method of cardiac risk assessment
WO2004031410A3 (en) Method for diagnosing testicular seminomas
WO2004053497A3 (en) Method for predicting the response to her2-directed therapy
SI1596868T1 (sl) Metoda zdravljenja hude srčne odpovedi in zdravilo za njo
EP1774029A4 (de) Verfahren zum nachweis des risikos und zur behandlung von typ-2-diabetes
GB0217333D0 (en) System and method for solution based multiparameter analysis of analytes
GB0419633D0 (en) Method and apparatus for the measurement of blood pressure
AU2003212405A1 (en) Method for determining the scale of an observation area
SI2196545T1 (sl) Postopki za napovedovanje odziva pacientov z multiplo sklerozo na terapijo z interferonom in diagnosticiranje multiple skleroze
EP1540353A4 (de) Teststreifen und verfahren zur bestimmung der ldl-cholesterinkonzentration aus vollblut
GB0200239D0 (en) Method for detecting human papillomavirus mRNA
AU2003230916A1 (en) Ex vivo method for determination of cetp activity and efficacy of heart disease treatment
ITLE20020017A1 (it) Apparato compiuterizzato per il rivelamento della dinamica articolare.
GB0409153D0 (en) Method of diagnosis
ATE521893T1 (de) P66-shc als prädiktiver marker bei der krebsbehandlung